HUTCHMED (China) (HCM) Cost of Revenue (2015 - 2021)
HUTCHMED (China) (HCM) posted quarterly Cost of Revenue of $12.3 million for Q2 2021, down 84.84% year-over-year from $81.0 million in Q2 2020, and up 114.09% quarter-over-quarter from $5.7 million in Q1 2021.
HUTCHMED (China) (HCM) Cost of Revenue (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Cost of Revenue for 6 consecutive years, with $12.3 million the latest figure, recorded in Q2 2021.
- In Q2 2021, Cost of Revenue fell 84.84% year-over-year to $12.3 million; the TTM figure through Jun 2021 stood at $101.6 million (up 13.12% YoY), while the FY2025 annual figure was $36.3 million, down 25.32% from the prior year.
- Cost of Revenue advanced to $12.3 million in Q2 2021 per HCM's latest filing, from $5.7 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $81.0 million in Q2 2020 and bottomed at $2.1 million in Q4 2019.
- Historically, Cost of Revenue has averaged $11.1 million across 4 years, with a median of $4.2 million in 2018.
- Annual changes were most pronounced in 2020 — Cost of Revenue soared 2079.17% — and 2021, when it slumped 84.84%.
- HUTCHMED (China)'s Cost of Revenue stood at $4.1 million in 2018, then sank by 49.4% to $2.1 million in 2019, then soared by 3823.35% to $81.0 million in 2020, then plunged by 84.84% to $12.3 million in 2021.
- Business Quant data shows HCM's Cost of Revenue at $12.3 million in Q2 2021, $5.7 million in Q1 2021, and $81.0 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | HUTCHMED (China) | 2.17 Bn | 2.17 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 12.27 Mn |
| Jun 30, 2021 | 12.27 Mn |
| Mar 31, 2021 | 5.73 Mn |
| Mar 31, 2021 | 5.73 Mn |
| Jun 30, 2020 | 80.98 Mn |
| Jun 30, 2020 | 80.98 Mn |
| Mar 31, 2020 | 2.59 Mn |
| Mar 31, 2020 | 2.59 Mn |
| Dec 31, 2019 | 2.06 Mn |
| Dec 31, 2019 | 2.06 Mn |
| Sep 30, 2019 | 4.16 Mn |
| Sep 30, 2019 | 4.16 Mn |
| Jun 30, 2019 | 3.72 Mn |
| Jun 30, 2019 | 3.72 Mn |
| Mar 31, 2019 | 3.79 Mn |
| Mar 31, 2019 | 3.79 Mn |
| Dec 31, 2018 | 4.08 Mn |
| Dec 31, 2018 | 4.08 Mn |
| Sep 30, 2018 | 4.27 Mn |
| Sep 30, 2018 | 4.27 Mn |